APA (7th ed.) Citation

Li, D., Xu, L., Liu, R., Yao, Z., Zheng, C., Jin, S., . . . Zhu, X. (2025). MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-06314-8

Chicago Style (17th ed.) Citation

Li, Di, et al. "MAZ-mediated N6-methyladenosine Modification of ZEB1 Promotes Hepatocellular Carcinoma Progression by Regulating METTL3." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-06314-8.

MLA (9th ed.) Citation

Li, Di, et al. "MAZ-mediated N6-methyladenosine Modification of ZEB1 Promotes Hepatocellular Carcinoma Progression by Regulating METTL3." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-06314-8.